Brandywine Global Investment Management’s PharMerica Corporation PMC Stock Holding History

Brandywine Global Investment Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-88,519	Closed	-$2.32M	–	964
2017 Q2	$2.32M	Buy	88,519 +74,359	+525%	+$1.83M	0.01%	556
2017 Q1	$332K	Sell	14,160 -10	-0.1%	-$247	﹤0.01%	648
2016 Q4	$357K	Buy	+14,170	New	+$358K	﹤0.01%	642
2014 Q2	–	Sell	-18,200	Closed	-$510K	–	1023
2014 Q1	$510K	Buy	+18,200	New	+$447K	﹤0.01%	622
2013 Q3	–	Sell	-34,000	Closed	-$472K	–	1059
2013 Q2	$472K	Buy	+34,000	New	+$482K	﹤0.01%	633

Other funds holding PMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brandywine Global Investment Management's PMC Position: Q3 2017 in Review

Brandywine Global Investment Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 88,519 shares — an estimated $2.32M sold.

Brandywine Global Investment Management first reported a position in PMC in Q2 2013 and held it in 5 quarters. The position peaked at $2.32M in Q2 2017. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

Brandywine Global Investment Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
Brandywine Global Investment Management sold 88,519 PharMerica Corporation shares in Q3 2017, an estimated $2.32M.
Brandywine Global Investment Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 5 quarters.
Brandywine Global Investment Management's PharMerica Corporation position peaked at $2.32M in Q2 2017.
150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Brandywine Global Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.